Funder: Pfizer Inc.
Due Dates: March 30, 2026 (Full proposal submission deadline)
Funding Amounts: Up to 2,000,000 JPY per project | Project duration: up to 2 years (June 1, 2026 – May 31, 2028)
Summary: Funds quality improvement initiatives to enhance medical care, professional skills, and collaborative networks for IBD patient care in Japan.
Key Information: Only organizations (not individuals) in Japan are eligible; clinical research and product efficacy studies are not supported.